Parkside Financial Bank & Trust grew its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 1.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,916 shares of the semiconductor company’s stock after purchasing an additional 29 shares during the quarter. Parkside Financial Bank & Trust’s holdings in Synopsys were worth $930,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Kieckhefer Group LLC purchased a new stake in shares of Synopsys during the 4th quarter valued at about $27,000. Whipplewood Advisors LLC purchased a new stake in Synopsys in the 4th quarter worth approximately $33,000. Hazlett Burt & Watson Inc. increased its holdings in Synopsys by 40.0% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after acquiring an additional 20 shares in the last quarter. Sierra Ocean LLC purchased a new stake in Synopsys in the 4th quarter worth approximately $39,000. Finally, Princeton Global Asset Management LLC purchased a new stake in Synopsys in the 3rd quarter worth approximately $44,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Analysts Set New Price Targets
SNPS has been the subject of several analyst reports. Loop Capital initiated coverage on shares of Synopsys in a report on Monday, November 11th. They issued a “buy” rating and a $675.00 target price for the company. Wells Fargo & Company reduced their target price on shares of Synopsys from $540.00 to $520.00 and set an “equal weight” rating for the company in a report on Thursday. Robert W. Baird reduced their target price on shares of Synopsys from $644.00 to $630.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. Needham & Company LLC reaffirmed a “buy” rating and set a $650.00 price objective on shares of Synopsys in a report on Thursday. Finally, Rosenblatt Securities reaffirmed a “buy” rating and set a $660.00 price objective on shares of Synopsys in a report on Tuesday. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $638.58.
Insider Activity at Synopsys
In related news, CRO Richard S. Mahoney sold 20,838 shares of the firm’s stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the completion of the transaction, the executive now directly owns 1,460 shares of the company’s stock, valued at approximately $738,774.60. This trade represents a 93.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.62% of the stock is currently owned by insiders.
Synopsys Stock Performance
SNPS stock opened at $454.71 on Friday. The firm has a fifty day moving average price of $506.84 and a 200 day moving average price of $516.13. Synopsys, Inc. has a fifty-two week low of $454.05 and a fifty-two week high of $624.80. The firm has a market cap of $70.29 billion, a PE ratio of 31.32, a price-to-earnings-growth ratio of 3.23 and a beta of 1.12.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
- Five stocks we like better than Synopsys
- Golden Cross Stocks: Pattern, Examples and Charts
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- How to invest in marijuana stocks in 7 stepsĀ
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.